Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Malignant Lymphoma

  Free Subscription


1 Am J Hematol
1 BMC Cancer
3 Bone Marrow Transplant
1 Br J Haematol
1 Cancer
1 Haematologica
2 Int J Radiat Oncol Biol Phys
1 J Biol Chem
1 J Clin Oncol
1 Leuk Lymphoma
1 Oncol Rep

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Hematol

  1. CARBONE A, Gloghini A
    Current and potential use of pathological targets in the treatment of Hodgkin lymphoma.
    Am J Hematol. 2018 Feb 2. doi: 10.1002/ajh.25054.
    PubMed     Text format    

    BMC Cancer

  2. SEKIMIZU M, Iguchi A, Mori T, Koga Y, et al
    Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol.
    BMC Cancer. 2018;18:122.
    PubMed     Text format     Abstract available

    Bone Marrow Transplant

  3. CASTAGNA L, Boubdallah R, Furst S, Coso D, et al
    Corrigendum: Disease status is a more reliable predictive factor than histology in lymphoma patients after reduced-intensity conditioning regimen and allo-SCT.
    Bone Marrow Transplant. 2018;53:234.
    PubMed     Text format     Abstract available

  4. GAUTHIER J, Holmberg L, Wu D, Bensinger W, et al
    Minimal detectable disease confirmed by flow cytometry and poor outcome after autologous stem cell transplantation in peripheral T-Cell lymphomas.
    Bone Marrow Transplant. 2016 Oct 24. doi: 10.1038/bmt.2016.
    PubMed     Text format    

  5. BAI L, Peters L, Xia W, Best G, et al
    Assessing pilot vial material as a surrogate for functional and phenotypic stem cell markers in cryopreserved haematopoietic stem cell product.
    Bone Marrow Transplant. 2016 Sep 26. doi: 10.1038/bmt.2016.
    PubMed     Text format    

    Br J Haematol

  6. ISHIDA T, Jo T, Takemoto S, Suzushima H, et al
    Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.
    Br J Haematol. 2018 Feb 7. doi: 10.1111/bjh.15123.
    PubMed     Text format    


  7. Erratum: Epperla N, Maddocks KJ, Salhab M, et al. C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy. Cancer. 2017;123:4411-4418.
    Cancer. 2018;124:867.
    PubMed     Text format    


  8. SHALABI H, Kraft IL, Wang HW, Yuan CM, et al
    Sequential loss of tumor surface antigens following chimeric antigen receptor T-cell therapies in diffuse large B-cell lymphoma.
    Haematologica. 2018 Feb 1. pii: haematol.2017.183459.
    PubMed     Text format     Abstract available

    Int J Radiat Oncol Biol Phys

  9. NG AK, Yahalom J, Goda JS, Constine LS, et al
    Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.
    Int J Radiat Oncol Biol Phys. 2018;100:652-669.
    PubMed     Text format     Abstract available

  10. RANA S, Holland J
    Coping With Knife: Postoperative Management of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Int J Radiat Oncol Biol Phys. 2018;100:547-548.
    PubMed     Text format    

    J Biol Chem

  11. BANTA KL, Wang X, Das P, Winoto A, et al
    B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors.
    J Biol Chem. 2018 Feb 2. pii: RA117.001101. doi: 10.1074/jbc.RA117.001101.
    PubMed     Text format     Abstract available

    J Clin Oncol

  12. ROEMER MGM, Redd RA, Cader FZ, Pak CJ, et al
    Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
    J Clin Oncol. 2018 Feb 2:JCO2017773994. doi: 10.1200/JCO.2017.77.3994.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  13. MARRERO WD, Cruz-Chacon A, Cabanillas F
    Mantle Cell Lymphoma with t(11;22) (q13;q11.2) an indolent clinical variant?
    Leuk Lymphoma. 2018 Feb 7:1-3. doi: 10.1080/10428194.2018.1427863.
    PubMed     Text format    

    Oncol Rep

  14. SONG YH, Zhong MZ, Chai Q, Gong KY, et al
    The role of aldehyde dehydrogenase 1A1 in B-cell non-Hodgkin's lymphoma.
    Oncol Rep. 2018 Jan 18. doi: 10.3892/or.2018.6220.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.